Literature DB >> 15029254

Similarities and differences in hepatitis B and C virus induced hepatocarcinogenesis.

Erzsébet Szabó1, Csilla Páska, Pál Kaposi Novák, Zsuzsa Schaff, András Kiss.   

Abstract

Hepatocellular carcinoma (HCC), the major manifestation of primary liver cancer, is one of the most frequent and malignant diseases worldwide. Among other environmental factors, hepatitis viruses, as the hepatitis B (HBV) and hepatitis C (HCV) viruses, are to be listed in the etiology of HCC. Both of these viruses cause a wide spectrum of clinical manifestations, ranging from healthy carrier state to acute and chronic hepatitis, cirrhosis and HCC. HBV and HCV are different viruses in structure: HBV contains a DNA genome which replicates through an RNA intermediate and requires an active viral reverse transcriptase (RT) polymerase enzyme, while HCV is an RNA virus which has no RT activity and replicates on the cellular membrane by RNA replication. In this review we discuss how these two biologically diverse viruses use common pathways to induce hepatocarcinogenesis despite their significant structural and viral cycle differences. A summary is also given of several observable common and different features. Direct integration of HBV viral sequences into the host genome increases the genomic instability, which does not occur in HCV infection. However, viral proteins may directly play a significant role in the induction of carcinogenesis by both viruses.

Entities:  

Mesh:

Year:  2004        PMID: 15029254     DOI: 10.1007/BF02893401

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  44 in total

1.  The scientific challenge of hepatitis C.

Authors:  J Cohen
Journal:  Science       Date:  1999-07-02       Impact factor: 47.728

Review 2.  Management of chronic hepatitis B.

Authors:  Hari S Conjeevaram; Anna Suk-Fong Lok
Journal:  J Hepatol       Date:  2003       Impact factor: 25.083

Review 3.  Genetics of hepatocellular carcinoma.

Authors:  M A Buendia
Journal:  Semin Cancer Biol       Date:  2000-06       Impact factor: 15.707

4.  Molecular pathogenesis of human hepatocellular carcinoma.

Authors:  Snorri S Thorgeirsson; Joe W Grisham
Journal:  Nat Genet       Date:  2002-08       Impact factor: 38.330

5.  Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver.

Authors:  X R Xu; J Huang; Z G Xu; B Z Qian; Z D Zhu; Q Yan; T Cai; X Zhang; H S Xiao; J Qu; F Liu; Q H Huang; Z H Cheng; N G Li; J J Du; W Hu; K T Shen; G Lu; G Fu; M Zhong; S H Xu; W Y Gu; W Huang; X T Zhao; G X Hu; J R Gu; Z Chen; Z G Han
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

6.  Hepatocellular carcinoma: an overview.

Authors:  P P Anthony
Journal:  Histopathology       Date:  2001-08       Impact factor: 5.087

7.  Smad4 overexpression in hepatocellular carcinoma is strongly associated with transforming growth factor beta II receptor immunolabeling.

Authors:  Michael Torbenson; Spyridon Marinopoulos; Duyen T Dang; Michael Choti; Raheela Ashfaq; Anirban Maitra; John Boitnott; Robb E Wilentz
Journal:  Hum Pathol       Date:  2002-09       Impact factor: 3.466

Review 8.  Hepatitis B virus infection and hepatocellular carcinoma: molecular genetics and clinical perspectives.

Authors:  P J Chen; D S Chen
Journal:  Semin Liver Dis       Date:  1999       Impact factor: 6.115

9.  Differential gene expression in distinct virologic types of hepatocellular carcinoma: association with liver cirrhosis.

Authors:  Norio Iizuka; Masaaki Oka; Hisafumi Yamada-Okabe; Naohide Mori; Takao Tamesa; Toshimasa Okada; Norikazu Takemoto; Kiichiro Hashimoto; Akira Tangoku; Kenji Hamada; Hironobu Nakayama; Takanobu Miyamoto; Shunji Uchimura; Yoshihiko Hamamoto
Journal:  Oncogene       Date:  2003-05-15       Impact factor: 9.867

10.  High expression of p21WAF1/CIP1 is correlated with human hepatocellular carcinoma in patients with hepatitis C virus-associated chronic liver diseases.

Authors:  Hidetaka Wagayama; Katsuya Shiraki; Kazushi Sugimoto; Takeshi Ito; Katsuhiko Fujikawa; Takenari Yamanaka; Koujiro Takase; Takeshi Nakano
Journal:  Hum Pathol       Date:  2002-04       Impact factor: 3.466

View more
  25 in total

1.  Hepatitis B virus genotyping by enzyme-linked immunosorbent assay in Taiwan.

Authors:  Shu-Fen Liu; Meng-Hsuan Hsieh; Nai-Jen Hou; Ming-Yen Hsieh; Jee-Fu Huang; Chia-Yen Dai; Ming-Lung Yu; Wan-Long Chuang
Journal:  Hepatol Int       Date:  2010-08-03       Impact factor: 6.047

2.  Absence of CD4 T-cell help provides a robust CD8 T-cell response while inducing effective memory in a preclinical model of melanoma.

Authors:  Maria Muccioli; Caitlin Longstaff; Fabian Benencia
Journal:  Immunotherapy       Date:  2012-05       Impact factor: 4.196

3.  Differences in characteristics of patients with and without known risk factors for hepatocellular carcinoma in the United States.

Authors:  Jon D Dorfman; Richard Schulick; Michael A Choti; Jean-Francois H Geschwind; Ihab Kamel; Michael Torbenson; Paul J Thuluvath
Journal:  World J Gastroenterol       Date:  2007-02-07       Impact factor: 5.742

Review 4.  Chemoprevention of hepatocellular carcinoma in patients with hepatitis C virus related cirrhosis.

Authors:  Gianni Testino; Paolo Borro
Journal:  World J Hepatol       Date:  2013-10-27

5.  Liver stiffness measurement in the risk assessment of hepatocellular carcinoma for patients with chronic hepatitis.

Authors:  Yuan-Hung Kuo; Sheng-Nan Lu; Chao-Hung Hung; Kwong-Ming Kee; Chien-Hung Chen; Tsung-Hui Hu; Chuan-Mo Lee; Chi-Sin Changchien; Jing-Houng Wang
Journal:  Hepatol Int       Date:  2010-10-08       Impact factor: 6.047

6.  Screening for hepatocellular carcinoma by Egyptian physicians.

Authors:  Sahar M Hassany; Ehab F Abdou Moustafa; Mohamed El Taher; Afaf Adel Abdeltwab; Hubert E Blum
Journal:  World J Gastrointest Oncol       Date:  2015-09-15

7.  Overexpression of MMSET is correlation with poor prognosis in hepatocellular carcinoma.

Authors:  Peng Zhou; Lie-Lin Wu; Ke-Min Wu; Wei Jiang; Jin-Dong Li; Le-du Zhou; Xin-Ying Li; Shi Chang; Yun Huang; Hui Tan; Ge-Wen Zhang; Feng He; Zhi-Ming Wang
Journal:  Pathol Oncol Res       Date:  2012-12-08       Impact factor: 3.201

8.  Chromogenic in situ hybridization analysis of Epidermal Growth Factor Receptor gene/chromosome 7 numerical aberrations in hepatocellular carcinoma based on tissue microarrays.

Authors:  Evangelos Tsiambas; Loukas Manaios; Costas Papanikolopoulos; Dimitrios N Rigopoulos; Dimitrios Tsounis; Andreas Karameris; Aspasia Soultati; Antigoni Koliopoulou; Christos Kravvaritis; Theodoros Sergentanis; Efstratios Patsouris; Spyridon Dourakis
Journal:  Pathol Oncol Res       Date:  2009-09       Impact factor: 3.201

9.  Hepatocellular carcinoma in Hepatitis C genotype 4 after viral clearance and in absence of cirrhosis: two case reports.

Authors:  Moutaz Derbala; Aliaa Amer
Journal:  Cases J       Date:  2009-09-15

Review 10.  Hepatocellular carcinoma, human immunodeficiency virus and viral hepatitis in the HAART era.

Authors:  Douglas C MacDonald; Mark Nelson; Mark Bower; Thomas Powles
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.